ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Tiansong Xie
Matched on OpenAlex author ID A5114130308. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: 2 papers · 2026: 2 papers
Papers 7
- Correction: Dual-energy CT extracellular volume fraction predicts tumor collagen ratio and possibly survival for inoperable pancreatic cancer patients. Co-author DOI 10.1007/s00330-025-12025-x↗
- Spectral CT-Based habitat imaging for the prediction of occult lymph node metastasis in resectable pancreatic ductal Adenocarcinoma: Pathological validation vi… Co-author DOI 10.1016/j.ejrad.2026.112679↗
- The preoperative prediction of lymph node metastasis of resectable pancreatic ductal adenocarcinoma using dual-layer spectral computed tomography. First author DOI 10.1007/s00330-024-11143-2↗
- Dual-energy CT extracellular volume fraction predicts tumor collagen ratio and possibly survival for inoperable pancreatic cancer patients. Co-author DOI 10.1007/s00330-024-11330-1↗
- Dual-layer spectral detector CT: A noninvasive preoperative tool for predicting histopathological differentiation in pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.ejrad.2024.111327↗
- Value of diffusion kurtosis MR imaging and conventional diffusion weighed imaging for evaluating response to first-line chemotherapy in unresectable pancreatic… Co-author DOI 10.1186/s40644-024-00674-y↗
- Pancreatic ductal adenocarcinoma: a radiomics nomogram outperforms clinical model and TNM staging for survival estimation after curative resection. Co-author DOI 10.1007/s00330-019-06600-2↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zhengrong Zhou · 7 shared papers, 2020–2026 · strength 1.73
- Paper Correction: Dual-energy CT extracellular volume fraction predicts tumor collagen ratio and possibly survival for inoper… DOI 10.1007/s00330-025-12025-x↗
- Paper Spectral CT-Based habitat imaging for the prediction of occult lymph node metastasis in resectable pancreatic ductal Ad… DOI 10.1016/j.ejrad.2026.112679↗
- Paper The preoperative prediction of lymph node metastasis of resectable pancreatic ductal adenocarcinoma using dual-layer sp… DOI 10.1007/s00330-024-11143-2↗
- Zehua Zhang · 5 shared papers, 2024–2026 · strength 1.30
- Paper Correction: Dual-energy CT extracellular volume fraction predicts tumor collagen ratio and possibly survival for inoper… DOI 10.1007/s00330-025-12025-x↗
- Paper The preoperative prediction of lymph node metastasis of resectable pancreatic ductal adenocarcinoma using dual-layer sp… DOI 10.1007/s00330-024-11143-2↗
- Paper Dual-energy CT extracellular volume fraction predicts tumor collagen ratio and possibly survival for inoperable pancrea… DOI 10.1007/s00330-024-11330-1↗
- Yi Chen · 2 shared papers, 2026 · strength 0.60
- Paper Correction: Dual-energy CT extracellular volume fraction predicts tumor collagen ratio and possibly survival for inoper… DOI 10.1007/s00330-025-12025-x↗
- Paper Spectral CT-Based habitat imaging for the prediction of occult lymph node metastasis in resectable pancreatic ductal Ad… DOI 10.1016/j.ejrad.2026.112679↗
- Wei Liu · 2 shared papers, 2026 · strength 0.60
- Paper Correction: Dual-energy CT extracellular volume fraction predicts tumor collagen ratio and possibly survival for inoper… DOI 10.1007/s00330-025-12025-x↗
- Paper Spectral CT-Based habitat imaging for the prediction of occult lymph node metastasis in resectable pancreatic ductal Ad… DOI 10.1016/j.ejrad.2026.112679↗
- Wei Liu · 2 shared papers, 2024–2025 · strength 0.49
- Paper Dual-energy CT extracellular volume fraction predicts tumor collagen ratio and possibly survival for inoperable pancrea… DOI 10.1007/s00330-024-11330-1↗
- Paper Dual-layer spectral detector CT: A noninvasive preoperative tool for predicting histopathological differentiation in pa… DOI 10.1016/j.ejrad.2024.111327↗
- Lei Chen · 1 shared paper, 2026 · strength 0.32
- Yi Chen · 1 shared paper, 2025 · strength 0.28
- Wei Liu · 1 shared paper, 2025 · strength 0.28
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.